TY - JOUR
T1 - Identification of a novel regulatory mechanism for norepinephrine transporter activity by the IP3 receptor
AU - Amano, Taiju
AU - Aoki, Shunsuke
AU - Setsuie, Rieko
AU - Sakurai, Mikako
AU - Wada, Keiji
AU - Noda, Mami
N1 - Funding Information:
This work was supported by research grants from the ministry of Health, Labour and Welfare of Japan, the ministry of Education, Culture, Sports, Science and Technology of Japan, and the National Institute of Biomedical Innovation (NIBIO).
PY - 2006/4/24
Y1 - 2006/4/24
N2 - The norepinephrine transporter (NET) plays a crucial role in noradrenergic neurotransmission and is a target of many antidepressants and psychostimulants. Intracellular Ca2+ is reportedly involved in regulating NET activity, but the detailed mechanism is not clear. We employed a norepinephrine uptake assay using SH-SY5Y cells and found that the IP3 receptor inhibitors, 2-aminoethoxydiphenyl borate and xestospongin C, reduced the NET Vmax. These reductions were accompanied by the decreased cell surface expression of NET. Our findings suggest that intracellular Ca2+ mobilized by IP3 receptor is required for the maintenance of NET activity. This adds another pathway involving Ca2+ for the regulation of NET to other known mechanisms providing intracellular Ca2+.
AB - The norepinephrine transporter (NET) plays a crucial role in noradrenergic neurotransmission and is a target of many antidepressants and psychostimulants. Intracellular Ca2+ is reportedly involved in regulating NET activity, but the detailed mechanism is not clear. We employed a norepinephrine uptake assay using SH-SY5Y cells and found that the IP3 receptor inhibitors, 2-aminoethoxydiphenyl borate and xestospongin C, reduced the NET Vmax. These reductions were accompanied by the decreased cell surface expression of NET. Our findings suggest that intracellular Ca2+ mobilized by IP3 receptor is required for the maintenance of NET activity. This adds another pathway involving Ca2+ for the regulation of NET to other known mechanisms providing intracellular Ca2+.
UR - http://www.scopus.com/inward/record.url?scp=33645802571&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33645802571&partnerID=8YFLogxK
U2 - 10.1016/j.ejphar.2006.02.041
DO - 10.1016/j.ejphar.2006.02.041
M3 - Article
C2 - 16554048
AN - SCOPUS:33645802571
SN - 0014-2999
VL - 536
SP - 62
EP - 68
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1-2
ER -